Relmada Therapeutics, Inc. Common Stock
$3.83
▲ +0.02
(+0.53%)
Volume: 1,311,047
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
22
- 21d momentum -15.8%
- MA aligned bearish
- RSI 33
🎯
Pullback
63
- RSI 33 near lows
- Near lower Bollinger band
- -9.5% vs 20MA
💎
Value
58
- -52% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)33.0
MACD-0.018
MA trendBearish
ATR6.28%
21d mom.-15.8%
63d mom.-42.8%
vs 20MA-9.5%
RVOL(20)1.05×
52w low · 2
52w high · 8
-52.1% from 52-week high
20d support 4
· resistance 5
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$406M
PER—
PBR1.97
PSR—
EPS$-0.58
ROE-30.0%
ROA-28.3%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA-6.07
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| -7.04% | -15.82% | -42.75% | -41.35% | +132.12% | -12.36% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -13.54%, daily vol 3.51%. Relmada Therapeutics, Inc. Common Stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.